Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events

Value in Health ◽

10.1016/j.jval.2020.12.012 ◽

2021 ◽

Author(s):

Edna Keeney ◽

Nicky J. Welton ◽

Matt Stevenson ◽

Michael N. Dalili ◽

José A. López-López ◽

...

Keyword(s):

Smoking Cessation ◽

United Kingdom ◽

Cost Effectiveness ◽

Adverse Events ◽

Cost Effectiveness Analysis ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

PDB3 COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR COMPARED TO NPH INSULIN IN PATIENTS WITH TYPE-2 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)65946-3 ◽

2004 ◽

Vol 7 (6) ◽

pp. 735-736

Author(s):

I Smith ◽

AJ Palmer ◽

S Roze ◽

T Kennedy-Martin

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Cost Effectiveness Analysis ◽

Nph Insulin ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett’s oesophagus in the United Kingdom

Current Medical Research and Opinion ◽

10.1080/03007995.2018.1552407 ◽

2019 ◽

Vol 35 (5) ◽

pp. 805-815 ◽

Author(s):

Vicki Pollit ◽

David Graham ◽

Catherine Leonard ◽

Alexandra Filby ◽

Jessica McMaster ◽

...

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

Barrett’S Oesophagus ◽

Barrett's Oesophagus ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

PSY14 A PATIENT-LEVEL COST-EFFECTIVENESS ANALYSIS OF IRON ISOMALTOSIDE VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN THE UNITED KINGDOM

Value in Health ◽

10.1016/j.jval.2020.04.1441 ◽

2020 ◽

Vol 23 ◽

pp. S373 ◽

Author(s):

R. Pollock ◽

G. Muduma

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Iron Deficiency ◽

Iron Deficiency Anemia ◽

Cost Effectiveness Analysis ◽

Deficiency Anemia ◽

Ferric Carboxymaltose ◽

Patient Level ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom

Cost Effectiveness and Resource Allocation ◽

10.1186/s12962-018-0153-4 ◽

2018 ◽

Vol 16 (1) ◽

Author(s):

Gabriel Tremblay ◽

Mike Dolph ◽

Sachin Patel ◽

Patricia Brandt ◽

Anna Forsythe

Keyword(s):

Acute Myeloid Leukemia ◽

United Kingdom ◽

Cost Effectiveness ◽

Myeloid Leukemia ◽

Standard Of Care ◽

Cost Effectiveness Analysis ◽

The United Kingdom ◽

Effectiveness Analysis ◽

Download Full-text

A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom

Journal of Medical Economics ◽

10.1080/13696998.2020.1745535 ◽

2020 ◽

Vol 23 (7) ◽

pp. 751-759 ◽

Author(s):

Richard F. Pollock ◽

Gorden Muduma

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Iron Deficiency ◽

Iron Deficiency Anemia ◽

Cost Effectiveness Analysis ◽

Deficiency Anemia ◽

Ferric Carboxymaltose ◽

Patient Level ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom

Journal of Medical Economics ◽

10.3111/13696998.2013.829079 ◽

2013 ◽

Vol 16 (10) ◽

pp. 1246-1254 ◽

Author(s):

Warren Mark Hart ◽

Paul Abrams ◽

Vicki Munro ◽

Peny Retsa ◽

Jameel Nazir

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Immediate Release ◽

Cost Effectiveness Analysis ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

A Cost Effectiveness Analysis of Everolimus Plus Exemestane Compared to Chemotherapy Agents for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom

Value in Health ◽

10.1016/j.jval.2014.08.2275 ◽

2014 ◽

Vol 17 (7) ◽

pp. A634

Author(s):

Z. Polanyi ◽

P. Dale ◽

M. Taylor ◽

L. Lewis ◽

J. Glanville ◽

...

Keyword(s):

Breast Cancer ◽

United Kingdom ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

The United Kingdom ◽

Effectiveness Analysis ◽

Chemotherapy Agents

Download Full-text

A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom

British Journal of Cancer ◽

10.1038/sj.bjc.6690836 ◽

1999 ◽

Vol 81 (7) ◽

pp. 1243-1247 ◽

Author(s):

C A Kennedy ◽

A M Gray ◽

A R Denman ◽

P S Phillips

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

The United Kingdom ◽

Effectiveness Analysis ◽

Residential Radon

Download Full-text

Author Correction: Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow’s Milk Protein Allergy in the United Kingdom

Journal of Health Economics and Outcomes Research ◽

10.36469/jheor.2021.28124 ◽

2021 ◽

Vol 8 (2) ◽

pp. 63

Author(s):

Rui Martins ◽

Mark P. Connolly ◽

Eleanor Minshall

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Milk Protein ◽

Cost Effectiveness Analysis ◽

Cow’S Milk ◽

The United Kingdom ◽

Effectiveness Analysis ◽

Cow’S Milk Protein

Download Full-text

PIN43 - A COST-EFFECTIVENESS ANALYSIS OF REVACCINATING OLDER ADULTS WITH THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO VACCINATING WITH A SINGLE DOSE OF PPV23 IN THE UNITED KINGDOM (UK)

Value in Health ◽

10.1016/j.jval.2018.09.1362 ◽

2018 ◽

Vol 21 ◽

pp. S228

Author(s):

Y. Jiang ◽

X. Yang ◽

S. Mahajan ◽

R. Gupta ◽

I.R. Matthews

Keyword(s):

Older Adults ◽

United Kingdom ◽

Single Dose ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text